This is a COVID-19 update for investors. Please click here to find related resources in Seoul.

Home > Industries > BT



Korea’s Bio Industry Competitiveness

Bio Industry Investment status

The total investment cost ofbio industry companies in 2019 wasKRW 7.987.9 billion, The totalinvestment in the bio-industry sectorwas KRW 2.586.4 billion,accounting for 32.3% of thetotal investment.

Bio Industry Investment status
Bio Industry growth

The total pharmaceuticalproduction in 2019 wasabout US$19.2 billion (KRW 22.31 trillion).and over the past 5 years the averageannual growth rate was 7.1%.

Bio Industry growth
Average annual Bio Industry workforce

Over the past five years,the amount of manpowerin the Bio Industryhas been continuouslyincreasing by 5.1%.

Average annual Bio Industry workforce
Number of bio-industry companies in Korea

Total 1,003

Number of bio-industry companies in Korea

Seoul's Bio Ecosystem

Seoul Biomedical business

21.9% of national biomedicalbusinesses are located in Seoul.
As Bio R&D occupies a relatively largeproportion, Seoul is characterized as anR&D center.

Seoul Biomedical business
Seoul’s biomedical businesses accountedfor 21.9%
Seoul’s biomedical businesses accountedfor 21.9%
The total investment cost of the bio industry ranks 4th among cities and provinces.
The total investment cost of the bio industry ranks 4th among cities and provinces.

Clinical Trial

Global Clinical Trial Trends

Korea recorded a global ranking ofmore than a dozen developmentsdue to the government's support forstrengthening new drugdevelopment capabilities andconducting rapid clinical trials.

Global Clinical Trial Trends
Global Clinical Trial Trends mobile

Bio Industry Sales

  • Domestic Bio Industry Sales
  • Increase by sectors